Zimmer Biomet Holdings, Inc. (ZBH)
| Previous close | 112.49 |
| Open | 114.41 |
| Bid | 114.88 x 800 |
| Ask | 114.89 x 800 |
| Day's range | 113.41 - 115.15 |
| 52-week range | 100.39 - 149.28 |
| Volume | |
| Avg. volume | 1,196,459 |
| Market cap | 24.119B |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | 83.30 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.96 (0.85%) |
| Ex-dividend date | 24 Jun 2022 |
| 1y target est | N/A |
- GlobeNewswire
Akerna Announces Financial Results for First Quarter 2022
Software revenue up 71%, total revenue up 73% year-over-yearDENVER, May 09, 2022 (GLOBE NEWSWIRE) -- Akerna (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, today reported its unaudited financial results for the quarter ended March 31, 2022. "As demand for Akerna’s platforms from cannabis operators, regulators, and brands continues to widen, we
- GlobeNewswire
Akerna Corp. Reminds Stockholders of Upcoming Annual Meeting; Urges Stockholders to Vote FOR all Proposals
DENVER, May 09, 2022 (GLOBE NEWSWIRE) -- Akerna Corp. (Nasdaq: KERN), a leading enterprise software company and developer of one of the most comprehensive technology infrastructures, ecosystems, and compliance engines powering the global cannabis industry, urges stockholders to vote FOR proposals put forth in the proxy statement prior to the Company’s May 13, 2022 annual stockholder meeting to be held at 9:00 am eastern time. Akerna common stockholders on the March 31, 2022 record date are entit
- GlobeNewswire
ZimVie Completes Separation from Zimmer Biomet; Announces Board of Directors
WESTMINSTER, Colo., March 01, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV) today announced its debut as an independent publicly traded company and the completion of its separation from Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH). This separation completes the path ZimVie began in 2021 when its former parent company announced its intention to separate its Dental and Spine businesses into one of the world’s newest and leading life sciences companies. ZimVie common stock began “regular
